Pharmafile Logo
Pharmafocus logo
Advanced Search
Chiesi image

Chiesi snaps up Zymenex

August 29, 2013
Sales and Marketing Chiesi, lamazym, rare diseases, zymenex

Chiesi Group is to acquire biopharma company Zymenex Holdings, allowing the Italian firm to enter the rare disease arena for …

News
steve_field_web

Steve Field becomes first GP chief inspector

August 29, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CQC, GP, steve field

Health services watchdog the Care Quality Commission has appointed Professor Steve Field as its first chief inspector of general practice. …

Appointment
pfizer_reflection

Oxford BioMedica gains $1 million Pfizer pay-out

August 29, 2013
Research and Development, Sales and Marketing Cancer, Oxford BioMedica, Pfizer, TroVax

News

Afinitor too costly for NICE despite price cut

August 29, 2013
Sales and Marketing Afinitor, HER2 negative, NICE, Novartis, breast cancer

News
Siegfried image

Siegfried buoyant as controlled substances lift 1H sales

August 28, 2013
Manufacturing and Production 1h, AMP, Siegfried

Pharmaceutical raw materials manufacturer Siegfried posted a 10% increase in sales to 197 million Swiss francs in the first half …

News
Lonza image

Lonza wields axe at US facility

August 28, 2013
Manufacturing and Production Lonza, cuts

Swiss contract manufacturer Lonza has said it will start cutting staffing levels at its US facility in Hopkinton, Massachusetts, next …

News
EMA image

Regulators produce QbD report

August 28, 2013
Manufacturing and Production, Sales and Marketing EMA, FDA, QbD

European and US regulators have published the first fruits of their collaboration on assessing measures to ensure drugs are manufactured …

News
NICE image

‘Inequality’ for Welsh cancer patients

August 28, 2013
Sales and Marketing CDF, Cancer, England, NHS, NICE, Wales

Cancer sufferers in England are four times more likely to receive newer treatments on the NHS than patients in Wales, …

News
shire_uk

Shire and Santaris extend rare disease alliance

August 28, 2013
Research and Development, Sales and Marketing Locked Nucleic Acid, Santaris, Shire, rare disease

News
bayer_cross_2

Nexavar gains FDA ‘speed lane’ status for thyroid cancer

August 28, 2013
Research and Development, Sales and Marketing Amgen, Nexavar, Onyx

News
ppd_david_johnston

PPD appoints David Johnston as executive vice president

August 28, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing PPD, david johnston

Contract research organisation PPD has appointed Dr David Johnston as executive vice president of global laboratory services. Johnston will direct …

Appointment

FDA warns Fresenius Kabi over plant problems

August 27, 2013
Manufacturing and Production FDA, Fresenius, kabi, recall

German drugmaker Fresenius has been sent another warning letter by the US Food and Drug Administration, this time for a …

News
Ovarian cells image

New ovarian cancer screening shows promise

August 27, 2013
Research and Development, Sales and Marketing ovarian cancer, screening

A new screening process for ovarian cancer is showing encouraging results, according to researchers in the US. In a trial …

News

Novartis R&D: looking for the ‘Sweet Spot’

August 27, 2013
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis, R&D, Vasella

Feature
astrazeneca_alderley

AstraZeneca buys cancer specialist

August 27, 2013
Research and Development, Sales and Marketing Amplimmune, AstraZeneca, Cancer, MedImmune

News
amgen

Amgen buys Onyx for $10.4 billion

August 27, 2013
Research and Development, Sales and Marketing Amgen, Kyprolis, Onyx

News
GSK image

GSK Crohn’s disease pill fails in Phase III

August 27, 2013
Sales and Marketing GSK, vercirnon

A late-stage trial of GlaxoSmithKline’s investigational Crohn’s disease drug failed to benefit patients. The SHIELD-1 study was investigating vercirnon – …

News
nhs_sign

AML-related revenues to nearly triple by 2017

August 26, 2013
Medical Communications, Sales and Marketing GlobalData, acute myeloid leukaemia

News
manufacturing_pharma

Pharma slow to adopt third-party certification?

August 23, 2013
Manufacturing and Production API, CPhI, manufacturing

News

Skin cancer death 70% more likely in men than women

August 23, 2013
Sales and Marketing CRUK, melanoma, skin cancer

News
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026